Saifuyuzu
4892.TPharmaceutical
Filed as Cyfuse Biomedical K.K. (2023-03–2026-08)
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Shizuka Akieda | 7.31% |
| Masahiro Sanjo | 6.74% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 3
| SBI Ventures Two Co., Ltd. | 4.64% |
| SBI Shinsei Bank, Limited | 2.24% |
| SBI SECURITIES Co., Ltd. | 0.83% |
Ownership history · 74
| Holder | Ratio | Change |
|---|---|---|
| SBI Ventures Two Co., Ltd.2025-09-02 · amended | 4.98% | -0.07pp |
| SBI SECURITIES Co., Ltd.2025-09-02 · amended | 7.31% | -1.11pp |
| SBI Shinsei Bank, Limited2025-08-22 · amended | 2.43% | -0.06pp |
| SBI Ventures Two Co., Ltd.2025-08-22 · amended | 5.05% | -0.11pp |
| SBI SECURITIES Co., Ltd.2025-08-22 · amended | 8.42% | -2.03pp |
| SBI Shinsei Bank, Limited2025-08-18 · amended | 2.49% | -0.03pp |
| SBI Ventures Two Co., Ltd.2025-08-18 · amended | 5.16% | -0.06pp |
| SBI SECURITIES Co., Ltd.2025-08-18 · amended | 10.45% | -1.17pp |
| SBI Shinsei Bank, Limited2025-08-04 · amended | 2.52% | -0.03pp |
| SBI Ventures Two Co., Ltd.2025-08-04 · amended | 5.22% | -0.06pp |
| SBI SECURITIES Co., Ltd.2025-08-04 · amended | 11.62% | -0.97pp |
| SBI Shinsei Bank, Limited2025-07-23 · amended | 2.55% | -0.03pp |
| SBI Ventures Two Co., Ltd.2025-07-23 · amended | 5.28% | -0.07pp |
| SBI SECURITIES Co., Ltd.2025-07-23 · amended | 12.59% | -1.01pp |
| SBI Shinsei Bank, Limited2025-07-14 · amended | 2.58% | -0.03pp |
| SBI Ventures Two Co., Ltd.2025-07-14 · amended | 5.35% | -0.06pp |
| SBI SECURITIES Co., Ltd.2025-07-14 · amended | 13.60% | -1.04pp |
| SBI Shinsei Bank, Limited2025-07-08 · amended | 2.61% | -0.08pp |
| SBI Ventures Two Co., Ltd.2025-07-08 · amended | 5.41% | -0.16pp |
| SBI SECURITIES Co., Ltd.2025-07-08 · amended | 14.64% | -2.40pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.